Gene Therapy and Biologic Analgesics

Commercial sector

Gene Therapy and Biologic Analgesics

Developers of gene therapies (viral vector-delivered transgenes, epigenome regulators, RNA therapeutics) or protein biologics (Fc-fusions, antibodies, engineered peptides) that modulate pain pathways through long-acting or disease-modifying mechanisms rather than conventional small-molecule pharmacology.

Companies17
Commercial products17
Technology classes1
Countries8
Patents171

Profiled companies

Products
  • Olipass logo
    Olipass
    South Korea2
  • Korro Bio logo
    Korro Bio
    United States2
  • AfaSci logo
    AfaSci
    United States1
  • Neurocarrus logo
    Neurocarrus
    United States2
  • Sekkei Bio Private Limited logo
    Sekkei Bio Private Limited
    India1
  • Tafalgie Therapeutics logo
    Tafalgie Therapeutics
    France4

+ 11 more

← Back to what’s inside this report